A University of Colorado Cancer Center study describes the activity of a recently discovered communication molecule of the body’s immune system, Interleukin 37 or IL-37. It has been known to limit inflammation and the current study reports its activity in the adaptive immune system, IL-37 inhibits the ability of the immune system to recognize and target new antigens. Knowing this mechanism that underlies IL-37’s effect on the immune system now allows us to study IL-37 function and perhaps dysfunction in a wide range of diseases. The study is published in the Proceedings of the National Academy of Sciences.
For example, knowing that IL-37 helps to create overall immune system sensitivity could allow researchers to manipulate IL-37 levels to sensitize the immune system to recognize and target tumour tissue, or desensitize the immune system in auto-immune conditions like rheumatoid arthritis in which the immune system acts over-aggressively toward healthy tissue.
IL-37 is one of the 38 known interleukins that carry messages in the immune system. The current study shows that IL-37 works through the regulation of dendritic cells, which trap, process and present new antigens. Dendritic cells are formed in bone marrow and migrate to parts of the body that commonly come in contact with new antigens, for example skin or the lining of the gut.
Immature dendritic cells are in a state of readiness, waiting at these common points of first contact to trap new antigens. Mature dendritic cells trap an antigen and then migrate with the antigen to lymph nodes where they work to coordinate the immune response to the new antigen.
The current study shows that IL-37 encourages the formation of semi-mature dendritic cells that migrate to lymph nodes but fail to present antigens in a way that create an immune response. It is as if IL-37 helps to maintain dendritic cells in a state of semi-immature readiness, rather than allowing them to become sensitized to new antigens.
In fact, the study showed a cascade of diminished immune system response in mice with IL-37, including lower CD40, IL-1b, IL-6 and IL-12, all of which are involved in creating an immune response. This implies that IL-37 may be a basic component of immune system regulation, with IL-37 levels affecting many other pieces of the overall response.
When researchers transplanted dendritic cells isolated from the lymph node of IL-37 mice and also dendritic cells isolated from wild-type (regular) mice into new mice, they saw much less ‘antigen challenge’ in mice that had received dendritic cells from IL-37 sources; these IL-37-expressing dendritic cells failed to sensitize the immune system and thus failed to create an immune response.
This is a case in which the medical community’s understanding of basic biology could translate into applications across many disease types.
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.